You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AtaiBeckley
since
auto-detected in 2 stories
6 days ago
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
9 days ago
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction ⊕
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
page 1 of 1